Supervised on-site dosing in injectable opioid agonist treatment-considering the patient perspective. Findings from a cross-sectional interview study in two German cities

Abstract Background Injectable opioid agonist treatment (iOAT) is an effective option to support people living with opioid use disorder (OUD) who have not sufficiently benefitted from oral OAT. However, iOAT has been criticised based on theoretical and practical grounds for its dosing policies: Curr...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Zoe Friedmann, Hans-Tilmann Kinkel, Claudia Kühner, Andreas Zsolnai, Inge Mick, Annette Binder
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2023-11-01
Colecção:	Harm Reduction Journal
Assuntos:	Injectable opioid agonist treatment Opioid use disorder Take-home doses Dosing policies Patient perspective Qualitative research
Acesso em linha:	https://doi.org/10.1186/s12954-023-00896-6
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!